Comment invited on GM E. coli chicken vaccine
The Office of the Gene Technology Regulator (OGTR) is calling for comment on the proposed commercial release of a genetically modified (GM) E. coli chicken vaccine.
Zoetis Australia Research and Manufacturing is applying for a licence application for a commercial release of Poulvac E. coli poultry vaccine that has been genetically modified to provide immunity to E. coli infection and disease.
The proposed release would be Australia wide and would be subject to any state government requirements imposed for marketing reasons as well as to approval by other regulatory authorities such as the Australian Pesticides and Veterinary Medicines Authority (APVMA), which regulates the use of vaccines in chickens.
To access the Risk Assessment and Risk Management Plan (RARMP) and related documents, visit the OGTR website: www.ogtr.gov.au.
Submissions close on 31 October 2014.
Two more Italian tomato exporters investigated for dumping
Vegetable producers and processors have welcomed an announcement that the Anti-Dumping Commission...
Global Food Safety Conference to feature LRQA, Cargill, Metro Group and World Bank
Representatives from LRQA, Cargill, Metro Group and the World Bank are among some of the keynote...
Labelling review recommends 'per serving' information be scrapped
The independent review of labelling has issued a recommendation that proposes the declaration in...
